Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients

被引:72
作者
Gannagé-Yared, MH
Azar, RR
Amm-Azar, M
Khalifé, S
Germanos-Haddad, M
Neemtallah, R
Halaby, G
机构
[1] France Hosp, Hotel Dieu, Div Endocrinol, Beirut, Lebanon
[2] St Joseph Univ, Sch Med, France Hosp, Hotel Dieu,Immunol Lab, Beirut, Lebanon
[3] St Joseph Univ, Sch Med, France Hosp, Hotel Dieu,Div Cardiol, Beirut, Lebanon
[4] Amer Univ Beirut, Div Clin Pathol, Beirut, Lebanon
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2005年 / 54卷 / 07期
关键词
D O I
10.1016/j.metabol.2005.02.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The effect of statins on insulin resistance is controversial and poorly studied in nondiabetic subjects. In addition, the effect of statins on leptin and adiponectin has never been studied. Methods: Forty healthy nondiabetic volunteers (22 men and 18 women) aged 28 to 72 were randomized either to placebo or pravastatin 40 mg daily for a 12-week period. Insulin resistance, assessed using the Quantitative Insulin Sensitivity Check Index (QUICKI), as well as serum leptin and adiponectin levels, was measured at baseline and at the end of therapy. Results: Pravastatin treatment decreased total cholesterol, low-density lipoprotein cholesterol, and triglycerides levels by 24%, 32%, and 14%, respectively (P <.05 for all), but did not affect glucose and insulin levels, the QUICKI index, and adiponectin and leptin levels. When stratification was performed according to QUICKI index or sex, no significant differences were observed in the prevalues and postvalues of leptin, adiponectin, or QUICKI index in the pravastatin group. Adiponectin, leptin, and QUICKI index were statistically higher in women than in men (P <.001 for both variables). Adiponectin was negatively correlated with body mass index (BMI; r = -0.39, P <.05) and positively correlated with the QUICKI index (r = 0.54, P <.001) and with high-density lipoprotein cholesterol (r = 0.50, P <.01). The relation between adiponectin and QUICKI index remained significant after adjustment for sex and BMI (P =.005 and P =.007, respectively). Leptin was only related to BMI (r = 0.57, P <.001) and to sex (P <.001) with no significant correlations with lipid parameters or QUICKI index. Both sex and BMI are independent predictors of leptin (P <.001 and P <.001). Conclusion: A 12-week treatment with pravastatin 40 mg/d does not change the QUICKI index and leptin and adiponectin levels in healthy volunteers. In addition, our results emphasize the importance of sex and BMI in the determination of both adiponectin and leptin. Adiponectin was also related to QUICKI index, whereas this relation was not found with leptin. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:947 / 951
页数:5
相关论文
共 31 条
  • [1] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
    Arita, Y
    Kihara, S
    Ouchi, N
    Takahashi, M
    Maeda, K
    Miyagawa, J
    Hotta, K
    Shimomura, I
    Nakamura, T
    Miyaoka, K
    Kuriyama, H
    Nishida, M
    Yamashita, S
    Okubo, K
    Matsubara, K
    Muraguchi, M
    Ohmoto, Y
    Funahashi, T
    Matsuzawa, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 79 - 83
  • [2] EFFECTS OF PRAVASTATIN, A 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR, ON GLUCOSE-TOLERANCE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    BABA, T
    KODAMA, T
    YAJIMA, Y
    ISHIZAKI, T
    [J]. DIABETES CARE, 1993, 16 (01) : 402 - 404
  • [3] Adiponectin relationship with lipid metabolism is independent of body fat mass:: Evidence from both cross-sectional and intervention studies
    Baratta, R
    Amato, S
    Degano, C
    Farina, MG
    Patanè, G
    Vigneri, R
    Frittitta, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2665 - 2671
  • [4] Serum immunoreactive leptin concentrations in normal-weight and obese humans
    Considine, RV
    Sinha, MK
    Heiman, ML
    Kriauciunas, A
    Stephens, TW
    Nyce, MR
    Ohannesian, JP
    Marco, CC
    McKee, LJ
    Bauer, TL
    Caro, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) : 292 - 295
  • [5] Hyperinsulinemia as an independent risk factor for ischemic heart disease
    Despres, JP
    Lamarche, B
    Mauriege, P
    Cantin, B
    Dagenais, GR
    Moorjani, S
    Lupien, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) : 952 - 957
  • [6] EGASHIRA K, 1994, CIRCULATION, V89, P2424
  • [7] Freeman DJ, 2001, CIRCULATION, V103, P357
  • [8] Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
    Hotta, K
    Funahashi, T
    Arita, Y
    Takahashi, M
    Matsuda, M
    Okamoto, Y
    Iwahashi, H
    Kuriyama, H
    Ouchi, N
    Maeda, K
    Nishida, M
    Kihara, S
    Sakai, N
    Nakajima, T
    Hasegawa, K
    Muraguchi, M
    Ohmoto, Y
    Nakamura, T
    Yamashita, S
    Hanafusa, T
    Matsuzawa, Y
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) : 1595 - 1599
  • [9] Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention.
    Hrebícek, J
    Janout, V
    Malincíková, J
    Horáková, D
    Cízek, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) : 144 - 147
  • [10] Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity
    Konstantinides, S
    Schäfer, K
    Koschnick, S
    Loskutoff, DJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (10) : 1533 - 1540